(Press-News.org) The largest study of its kind has shown the most effective test for the diagnosis of Clostridium difficile (C-Diff), a bacterial infection which causes 15,000-20,000 deaths a year in hospitals in the United States.
C-Diff affects the digestive system, and is most common in hospital patients treated with antibiotics for other infections.
The multi-centre study, carried out by UK researchers at the University of Leeds, in partnership with colleagues from the University of Oxford, University College London and St George's, University of London, tested more than 12,000 faecal samples from hospital patients to establish the best method for diagnosing C-Diff.
The findings have been published online in the journal Lancet Infectious Diseases today (Tuesday 3 September).
The study compared the main different ways of diagnosing C-Diff, including the two 'gold-standard' methods: a cytotoxin assay, which looks for the presence of C-Diff toxin in faecal samples; and cytotoxigenic culture, which looks to see if there are bugs present in faecal samples that could possibly produce C-Diff toxin.
The research team found that patients with faecal samples positive by the cytotoxin assay were almost twice as likely to die within 30 days as those patients with samples only positive by the alternative 'gold-standard' method (16.6% versus 9.7%). The findings mean that tests which detect the presence of toxin in faecal samples (the cytotoxin assay) are the most reliable indicators of true C-Diff.
Professor Mark Wilcox, of the University of Leeds and Leeds Teaching Hospitals NHS Trust, who is also the C-Diff lead for Public Health England, the nation's public health body, said:
"The diagnosis of C-Diff has become a complicated area with lots of alternative tests, and there has been considerable uncertainty about which are the best tests to use.
"This is a landmark study not only because of its size, but also because we followed what happened to patients. This meant we have been able to show confidently which are the best tests to use to diagnose C-diff.
"C-diff cases in the NHS have decreased markedly in number since their peak in 2007-08 but reliably diagnosing C-diff is a crucial way forward to continuing to fight this infection."
These findings highlight the importance of using appropriate tests to diagnose C-Diff, especially as it is not possible to diagnose the infection using laboratory tests. Treating patients for C-diff and preventing the spread of infections in hospitals rely on accurately identifying who has the infection, but also who may be capable of transmitting the bug. The study identified a way of using a combination of tests to identify who has C-diff and who could be at risk of spreading the bug to others.
###
The research has already been used as a basis for new 2012 guidelines to the National Health Service (NHS) on the diagnosis of C-Diff.
The study was carried out at four UK hospital sites between October 2010 and September 2011: Leeds Teaching Hospitals NHS Trust, St George's Healthcare NHS Trust, Oxford University Hospitals NHS Trust and University College London Hospitals NHS Foundation Trust.
The study was funded by the UK Department of Health and the Health Protection Agency, now known as Public Health England.
Further information
Dr Mark Wilcox is available for interview. Please contact Ben Jones, Press Officer, on +44 (0)113 34 38059 or email B.P.Jones@leeds.ac.uk
University of Leeds
The 2008 Research Assessment Exercise showed the University of Leeds to be the UK's eighth biggest research powerhouse. The University is one of the largest higher education institutions in the UK and a member of the Russell Group of research-intensive universities. The University's vision is to secure a place among the world's top 50 by 2015. http://www.leeds.ac.uk
Level playing field for Clostridium difficile diagnosis
2013-09-03
ELSE PRESS RELEASES FROM THIS DATE:
Recommendations for removing copyright hurdles to scientific research
2013-09-03
The EU e-infrastructure coordination pro-iBiosphere project is preparing the ground for the pursuit of biological research in the digital age. In its "Draft policy for Open Access to data and information" scientists and lawyers recommend that hurdles posed by copyright and database protection should be removed by establishing exceptions for research in a new binding, Europe-wide regulation. This report opens a consultation process that will last until December 2013. Input is welcomed on pro-iBiosphere's Google+ , LinkedIn or Facebook.
At present, national provisions ...
Recommendations on how to move the naming of organisms from paper and on to the Internet
2013-09-03
"Well, I suppose I'd better start finding names for things…" was the first thing said by the ill-fated sperm whale (Physeter macrocephalus Linnaeus, 1758) in Douglas Adam's Hitchhikers Guide to the Galaxy. Such is the richness of life that, unlike that whale, mankind is still naming things. Without commonly accepted names there would be no way to communicate research about life and it is the profession of taxonomists to put names on organisms and describe the different forms of life on Earth.
The EU e-Infrastructure coordination project "pro-iBiosphere", targeting the ...
The future of biodiversity publishing
2013-09-03
The traditional audience for books and scientific papers in which scientists report their findings has been the human reader. Now we can enhance publications by attaching to them many different kinds of digital objects (such as the sounds made by birds, maps that show where they occur, or images and videos) or by adding computer-readable sections and terms that allow computers to extract information for re-use. We refer to these enriched and marked-up documents as 'enhanced'.
While the technology is available, only a tiny proportion of scientific publications are enhanced. ...
Rim Fire update Sept. 02, 2013
2013-09-03
The Rim Fire in and around Yosemite National Park, which began on August 17, 2013 is now the fourth largest fire in California's history. According to Inciweb.org for Sept. 02, 2013: "The Rim Fire grew approximately 8,310 acres, to a total size of 231,088 acres. Burnout operations on the northern and southern portions of the fire continued with success through the night. Southwest transport winds returned smoke to the communities northeast of the fire, including Reno, Carson City, Markleeville, Minden, and the Lake Tahoe Basin, and returned clearer skies to the Yosemite ...
Action-inaction balance in cultural values more common in East Asian countries
2013-09-03
PHILADELPHIA -- People in East Asian countries seem to strike the best balance between liking action and inaction, whereas someone from the Mediterranean area of the world are far less likely to have achieved the same balance.
This balance between action and inaction is best displayed in Asia, where Labor Day is not observed until May.
A two-year-long study involving over 4,000 volunteer participants (age 19 to 30) from 19 countries and looked at the degree to which a culture holds attitudes toward rest and activity. It was led by Dolores Albarracín, Ph.D., the Martin ...
LEGATO at the 6th International ESP Conference
2013-09-03
On August 28th the LEGATO project team held a successful workshop on rice ecosystem services and ecological engineering at the 6th Annual International Conference of the Ecosystem Services Partnership (ESP) in Bali, Indonesia. The session titled "Rice Ecosystem Services" illustrated the conference motto "Making Ecosystem Services Count!" by presenting the interlinkage of different dimensions of ecosystem service research in LEGATO and collaborating projects, from water management and pollution, via the role of bio-indicator species, in particular of dragonflies (to signalise ...
JCI early table of contents for Sept. 3, 2013
2013-09-03
Enhanced luminal breast tumor response to antiestrogen therapy
Breast cancer can be divided into 4 major subtypes using molecular and genetic information from the tumors. Each subtype is associated with different prognosis and should be taken into consideration when making treatment decisions. In this issue of the Journal of Clinical Investigation, Rebecca Cook and colleagues at Vanderbilt University, found that expression of an oncogene, ERBB3, was enhanced in luminal breast cancers compared to other breast cancer subtypes. Addition of the ERBB3 protein to cultured ...
Enhanced luminal breast tumor response to antiestrogen therapy
2013-09-03
Breast cancer can be divided into 4 major subtypes using molecular and genetic information from the tumors. Each subtype is associated with different prognosis and should be taken into consideration when making treatment decisions.
In this issue of the Journal of Clinical Investigation, Rebecca Cook and colleagues at Vanderbilt University, found that expression of an oncogene, ERBB3, was enhanced in luminal breast cancers compared to other breast cancer subtypes. Addition of the ERBB3 protein to cultured luminal breast cancer cells increased the growth of the cells; ...
Peritoneal dialysis as an intervention for stroke patients
2013-09-03
Ischemic stroke is characterized by an interruption of the blood supply to the brain, which can lead to brain damage and even death. Excess amounts of the excitatory neurotransmitter glutamate are released during stroke events and further exacerbate brain cell death. Currently, there are no effective strategies for combatting the effects ischemic stroke.
In this issue of the Journal of Clinical Investigation , José Sánchez-Prieto and colleagues at the Universidad Complutense demonstrate that peritoneal dialysis is an effective treatment for reducing glutamate levels ...
Hormone may help fight obesity and reduce cholesterol
2013-09-03
Research has shown that giving obese rodents a recently identified circulating protein called fibroblast growth factor 21 (FGF21) helps improve their metabolism. Now investigators reporting in the Cell Press journal Cell Metabolism reveal that a variant of FGF21 has similar effects in obese people with type 2 diabetes.
"Our findings suggest that FGF21 has the ability to favorably affect body weight and to partially normalize abnormal lipid levels in patients with diabetes. These are substantial issues and unmet medical needs for patients with obesity and type 2 diabetes," ...